Adezunap

N/A

Report date: 2024/01/25 10:30:07

Base Information

Drug NameAdezunap
Drug Alias NameAP-707
ClassificationNatural product/Extract > Plants extract
Mechanisms of ActionCannabinoid CB1 receptor agonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsDiabetic peripheral neuropathySomatoform DisordersAccidental Injuries +[19
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesCannaXan GmbH
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathySomatoform DisordersAccidental Injuries +[19
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A